omniture

WuXi PharmaTech RESCHEDULES Second-Quarter 2010 Earnings Conference Call

2010-07-31 01:07 1372

SHANGHAI, July 31 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the second quarter of 2010 on Monday, August 2, 2010, before the U.S. market opens.

(Logo: http://www.prnasia.com/sa/200809231435.jpg )

The earnings release will be available on the investor relations section of its website at http://www.wuxiapptec.com .

Following the earnings announcement, WuXi PharmaTech senior management will host a conference call at 10:00 am (Eastern) / 7:00 am (Pacific) / 10:00 pm (Beijing/Shanghai/Hong Kong) on Monday, August 2, 2010, to discuss its second-quarter 2010 financial results and recent business activities. The conference call may be accessed by calling:

United States: 1-866-519-4004

China (Landline): 800-819-0121

China (Mobile): 400-620-8038

Hong Kong: 800-930-346

United Kingdom: 0-808-234-6646

International: +65-6723-9381

Conference ID: 90840146

Web PIN: 8656

A replay will be available two hours after the call's completion at:

United States: 1-866-214-5335

China North: 10-800-714-0386

China South: 10-800-140-0386

Hong Kong: 800-901-596

United Kingdom: 0-800-731-7846

International: +61-2-8235-5000

Passcode: 90840146

A live webcast of the conference call and replay will be available in the investor relations section of WuXi PharmaTech's website at http://www.wuxiapptec.com .

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to help its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec. For more information, please visit: http://www.wuxiapptec.com .

For more information, please contact:

Ronald Aldridge

Director of Investor Relations

Phone: +1-201-585-2048

Email: ir@wuxiapptec.com

Source: WuXi PharmaTech (Cayman) Inc.
Related Stocks:
NYSE:WX
collection